ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2019

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date.

Sam Pearson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.